certify
|
Home › Pharma › Biotech › Page 7

Biotech

FDA Approves a High-Performance Stent – First of its Kind in Nearly Two Decades
Biotech News
FDA Approves a High-Performance Stent – First of its Kind in Nearly Two Decades
September 19, 2018 12526 Views
The Food and Drug Administration (FDA) just approved a new covered coronary stent device meant to treat perforations ...
Read more    
Vital Therapies’ Stock Plummets After Phase 3 Trial For Liver Disease Flops
Biotech Pharma
Vital Therapies’ Stock Plummets After Phase 3 Trial For Liver Disease Flops
September 17, 2018 4082 Views
Biotech company, Vital Therapies’ stock plunged by almost 89 percent after a Phase III trial of its cell ...
Read more    
Atreca’s $125M round brings new immunotherapy closer to clinical trials
Biotech Investing & Startups
Atreca’s $125M round brings new immunotherapy closer to clinical trials
September 17, 2018 8602 Views
Atreca, Inc., a biotechnology  company focused on developing novel therapeutics based on a deep understanding of the human ...
Read more    
OncoResponse Raised $40M for Unique Drug Candidates Clinical Studies
Biotech Investing & Startups
OncoResponse Raised $40M for Unique Drug Candidates Clinical Studies
September 13, 2018 3901 Views
OncoResponse, a biotech startup formed with the University of Texas M.D. Anderson Cancer Center in Houston, announced, September ...
Read more    
4D Molecular Therapeutics Raises $90M; Clinical Testing for Gene Therapies
Biotech Pharma
4D Molecular Therapeutics Raises $90M; Clinical Testing for Gene Therapies
September 13, 2018 1026 Views
Gene therapy firm, 4D Molecular Therapeutics (4DMT) is on the verge of taking its therapies for adeno-associated viruses ...
Read more    
Inscripta Acquires Solana As It Accelerates Commercialization Drive
Biotech Healthcare Tech Investing & Startups
Inscripta Acquires Solana As It Accelerates Commercialization Drive
September 12, 2018 3554 Views
Genome editing company, Inscripta has announced the acquisition of life sciences firm, Solana Biosciences, in a move meant ...
Read more    
Pfizer puts a stop on its clinical studies for a potential DMD drug
Biotech Pharma
Pfizer puts a stop on its clinical studies for a potential DMD drug
September 10, 2018 3380 Views
Patients suffering from Duchenne muscular dystrophy (DMD) and their families received disappointing news recently, when Pfizer Inc. announced ...
Read more    
Arvinas goes public to bring its PROTAC-based anticancer drug to the market looking at an $100 mn IPO
Biotech Pharma
Arvinas goes public to bring its PROTAC-based anticancer drug to the market looking at an $100 mn IPO
September 1, 2018 6557 Views
On August 30th Arvinas, a preclinical biotech that is developing protein therapies for metastatic cancers, filed with the ...
Read more    
UK Biotech Company Raises $84 Million for Novel Cancer Therapies
Biotech Healthcare Tech Innovation Investing & Startups Pharma
UK Biotech Company Raises $84 Million for Novel Cancer Therapies
August 24, 2018 5153 Views
A United Kingdom based biotechnology company focusing on novel cancer therapies has secured $84 million in a Series ...
Read more    
banner
Adsense
Healthcare Weekly

SOCIAL MEDIA


Contact Us Advertising / Sponsorships
© Copyright 2024 Healthcare Weekly.
Privacy Policy | Terms of Service | Cookie Policy
[email protected]
Healthcare Weekly
© Copyright 2024 Healthcare Weekly